Celiac.com Sponsor (A1):

Celiac.com Sponsor (A1-m):


This topic is now archived and is closed to further replies.

Scott Adams

Biolinerx (Blrx) Announces Presentation Of Positive Bl-7010 Phase 1/2 Data ... - Streetinsider.com

Recommended Posts

BioLineRx (BLRX) Announces Presentation of Positive BL-7010 Phase 1/2 Data ...


BioLineRx (NASDAQ: BLRX) announced that it will present positive safety results of its Phase 1/2 study for BL-7010, a novel polymer for the treatment of celiac disease, at the 16th International Celiac Disease Symposium (ICDS 2015), to take place from ...

Stock Update (NASDAQ:BLRX): Bioline RX Ltd to Present Successful Results of ... Smarter Analyst

all 4 news articles »

View the full article

Scott Adams

Celiac.com - Celiac Disease Board Moderator

Founder Celiac.com

Share this post

Link to post
Share on other sites

Join eNewsletter

Celiac.com Sponsor (A8):

Celiac.com Sponsor (A8):

Join eNewsletter